Sulfin pyrazone

Sulfin pyrazone(: Sulfinpyrazone) is one of used for treatment. Sulfin pyrazone sometimes inhibits platelet aggregation by inhibiting the release of and inhibiting it.

Sulfin pyrazone - - Substance name by

1,2-diphenyl-4- [2- (phenylsulfinyl) ethyl] pyrazolidine-3,5-dione

Clinical data | Anzuran | oral intravenous data | 98-99% | hepatic | renal Identification

| | () | CID: | | Chemical data | 232023 | 404.48 g / mol

Sulfin pyrazone competitively antagonizes reabsorption in the same as other uricosurics.

In Japan, the company sold it as Anzuran®, but now it is discontinued.

Contraindication

Sulffin pyrazone should not be administered to patients with kidney dysfunction or patients with hyperuricuria. .

Source · Footnote

1. *Underwood M (June 2006).. __*332(7553): 1315-9.:.

Related item

• This item is related to***. Please do (//). — | —

Acquired from ""

Post Date : 2018-03-02 21:30

This article is taken from the Japanese Wikipedia Sulfin pyrazone

This article is distributed by cc-by-sa or GFDL license in accordance with the provisions of Wikipedia.

Wikipedia and Tranpedia does not guarantee the accuracy of this document. See our disclaimer for more information.

In addition, This site is simply not responsible for any show is only by translating the writings of foreign licenses that are compatible with CC-BY-SA license information.